Table 4.
Vitamin D3 concentration depending on VDR receptor polymorphisms (Apa-I, Taq-I, Bsm-I and Fok-I) in ASD patients.
| VDR Gene Polymorphism | No. of Patients | Concentration (ng/mL) | SEM | p-Value |
|---|---|---|---|---|
| Apa-I | ||||
| Aa | 9 | 41.6 (21.2–71.1) | 13.4 | 0.07 |
| AA | 10 | 57.2 (19.9–72.5) | 15.1 | |
| Taq-I | ||||
| TT | 4 | 48.8 (36.3–71.1) | 15.8 | 0.71 |
| Tt | 11 | 48.5 (19.9–72.5) | 14.7 | |
| Tt | 4 | 52.3 (21.2–71.0) | 17.1 | |
| Bsm-I | ||||
| BB | 5 | 48 (26.2–69.4) | 12.2 | 0.92 |
| Bb | 7 | 54.9 (21.2–72.5) | 21.2 | |
| Bb | 7 | 52.4 (31.3–72.2) | 18.8 | |
| Fok-I | ||||
| FF | 7 | 52.7 (31.3–72.5) | 13.1 | 0.21 |
| Ff | 8 | 50.3 (21.2–72.2) | 10.6 | |
| ff | 4 | 30.6 (19.9–45.5) | 11.7 |